Your browser doesn't support javascript.
loading
Myeloablative Conditioning for Allogeneic Transplantation Results in Superior Disease-Free Survival for Acute Myelogenous Leukemia and Myelodysplastic Syndromes with Low/Intermediate but not High Disease Risk Index: A Center for International Blood and Marrow Transplant Research Study.
Bejanyan, Nelli; Zhang, Meijie; Bo-Subait, Khalid; Brunstein, Claudio; Wang, Hailin; Warlick, Erica D; Giralt, Sergio; Nishihori, Taiga; Martino, Rodrigo; Passweg, Jakob; Dias, Ajoy; Copelan, Edward; Hale, Gregory; Gale, Robert Peter; Solh, Melhem; Kharfan-Dabaja, Mohamed A; Diaz, Miguel Angel; Ganguly, Siddhartha; Gore, Steven; Verdonck, Leo F; Hossain, Nasheed M; Kekre, Natasha; Savani, Bipin; Byrne, Michael; Kanakry, Christopher; Cairo, Mitchell S; Ciurea, Stefan; Schouten, Harry C; Bredeson, Christopher; Munker, Reinhold; Lazarus, Hillard; Cahn, Jean-Yves; van Der Poel, Marjolein; Rizzieri, David; Yared, Jean A; Freytes, Cesar; Cerny, Jan; Aljurf, Mahmoud; Palmisiano, Neil D; Pawarode, Attaphol; Bacher, Vera Ulrike; Grunwald, Michael R; Nathan, Sunita; Wirk, Baldeep; Hildebrandt, Gerhard C; Seo, Sachiko; Olsson, Richard F; George, Biju; de Lima, Marcos; Hourigan, Christopher S.
Affiliation
  • Bejanyan N; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida. Electronic address: nelli.bejanyan@moffitt.org.
  • Zhang M; Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Bo-Subait K; Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Brunstein C; Adult Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, Minnesota.
  • Wang H; Division of Biostatistics, Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Warlick ED; Adult Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, Minnesota.
  • Giralt S; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Nishihori T; Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, Florida.
  • Martino R; Division of Clinical Hematology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Passweg J; Division of Hematology, Department of Internal Medicine, University Hospital Basel, Basel, Switzerland.
  • Dias A; Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Copelan E; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.
  • Hale G; Department of Hematology/Oncology, Johns Hopkins All Children's Hospital, St Petersburg, Florida.
  • Gale RP; Haematology Research Centre, Department of Immunology and Inflammation, Imperial College London, London, UK.
  • Solh M; Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, Georgia.
  • Kharfan-Dabaja MA; Division of Hematology-Oncology, Blood and Marrow Transplantation Program, Mayo Clinic, Jacksonville, Florida.
  • Diaz MA; Department of Hematology/Oncology, Hospital Infantil Universitario Nino Jesus, Madrid, Spain.
  • Ganguly S; Division of Hematological Malignancy and Cellular Therapeutics, University of Kansas Health System, Kansas City, Kansas.
  • Gore S; Section of Medical Oncology, Department of Internal Medicine, Yale New Haven Hospital, New Haven, Connecticut.
  • Verdonck LF; Department of Hematology/Oncology, Isala Clinic, Zwolle, The Netherland.
  • Hossain NM; Stem Cell Transplant Program, Division of Hematology/Oncology, Department of Medicine, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois.
  • Kekre N; Blood & Marrow Transplant Program, Department of Medicine, Ottawa Hospital Ottawa, Ontario, Canada.
  • Savani B; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Byrne M; Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Kanakry C; Experimental Transplantation and Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Cairo MS; Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Department of Pediatrics, New York Medical College, Valhalla, New York.
  • Ciurea S; Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Schouten HC; Department of Hematology, Academische Ziekenhuis, Maastricht, The Netherlands.
  • Bredeson C; Blood & Marrow Transplant Program, Department of Medicine, Ottawa Hospital Ottawa, Ontario, Canada.
  • Munker R; Division of Medical Oncology, Markey Cancer Center, University of Kentucky School of Medicine, Lexington, Kentucky.
  • Lazarus H; Department of Medicine, University Hospitals Cleveland Medical Center, Case Western Reserve University, Cleveland, Ohio.
  • Cahn JY; Department of Hematology, CHU Grenoble Alpes, Grenoble, France.
  • van Der Poel M; Department of Internal Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands.
  • Rizzieri D; Division of Hematologic Malignancies and Cellular Therapy, Duke University, Durham, North Carolina.
  • Yared JA; Blood & Marrow Transplantation Program, Division of Hematology/Oncology, Department of Medicine, Greenebaum Comprehensive Cancer Center, University of Maryland, Baltimore, Maryland.
  • Freytes C; Hematopoietic Stem Cell Transplant Program, Texas Transplant Institute, San Antonio, Texas.
  • Cerny J; Division of Hematology/Oncology, Department of Medicine, University of Massachusetts Medical Center, Worcester, Massachusetts.
  • Aljurf M; Department of Oncology, King Faisal Specialist Hospital Center & Research, Riyadh, Saudi Arabia.
  • Palmisiano ND; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.
  • Pawarode A; Blood and Marrow Transplantation Program, Division of Hematology/Oncology, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
  • Bacher VU; Department of Hematology, Inselspital, Bern University Hospital, University of Bern, Switzerland.
  • Grunwald MR; Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Atrium Health, Charlotte, North Carolina.
  • Nathan S; Section of Bone Marrow Transplantation and Cellular Therapy, Division of Hematology, Oncology and Cell Therapy, Department of Internal Medicine, Rush Medical College, Chicago, Illinois.
  • Wirk B; Bone Marrow Transplant Program, Penn State Cancer Institute, Hershey, Pennsylvania.
  • Hildebrandt GC; Division of Medical Oncology, Markey Cancer Center, University of Kentucky School of Medicine, Lexington, Kentucky.
  • Seo S; Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan.
  • Olsson RF; Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden; Centre for Clinical Research Sormland, Uppsala University, Sweden.
  • George B; Department of Haematology, Christian Medical College, Vellore, India.
  • de Lima M; Department of Medicine, Seidman Cancer Center, University Hospitals Case Medical Center, Cleveland, Ohio.
  • Hourigan CS; Laboratory of Myeloid Malignancies, National Heart Lung and Blood Institute, National Institutes of Health, Bethesda, Maryland.
Transplant Cell Ther ; 27(1): 68.e1-68.e9, 2021 01.
Article in En | MEDLINE | ID: mdl-33010430
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Transplant Cell Ther Year: 2021 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Myelodysplastic Syndromes / Leukemia, Myeloid, Acute / Hematopoietic Stem Cell Transplantation Type of study: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Humans / Middle aged Language: En Journal: Transplant Cell Ther Year: 2021 Type: Article